Litcius/Paper detail

A Multicohort Open-label Phase II Trial of Bipolar Androgen Therapy in Men with Metastatic Castration-resistant Prostate Cancer (RESTORE): A Comparison of Post-abiraterone Versus Post-enzalutamide Cohorts

Mark C. Markowski, Hao Wang, Rana Sullivan, Irina Rifkind, Victoria J. Sinibaldi, Michael T. Schweizer, Benjamin A. Teply, Nduku Ngomba, Wei Fu, Michael A. Carducci, Channing J. Paller, Catherine H. Marshall, Mario A. Eisenberger, Jun Luo, Emmanuel S. Antonarakis, Samuel R. Denmeade

2020European Urology83 citationsDOIOpen Access PDF

Topics & Concepts

MedicineEnzalutamideProstate cancerAbirateroneOncologyInternal medicineAndrogen deprivation therapyUrologyAndrogenAbiraterone acetateOpen labelCancerClinical trialAndrogen receptorHormoneProstate Cancer Treatment and ResearchAdvanced Breast Cancer TherapiesHormonal and reproductive studies
A Multicohort Open-label Phase II Trial of Bipolar Androgen Therapy in Men with Metastatic Castration-resistant Prostate Cancer (RESTORE): A Comparison of Post-abiraterone Versus Post-enzalutamide Cohorts | Litcius